Keywords: avanir, abreva, oked, canada, pharmaceuticals, been, granted
Avanir's Abreva OKed in Canada
Article | 03 June 2002
Avanir Pharmaceuticals has been granted approval in Canada to sell itscold sore treatment Abreva (docosanol 10% cream) as an over-the-counter product. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
